Rafael Calais Gaspar

机构：Universidade Estadual de Campinas (UNICAMP), Yale University, University of New Haven, SUPERA Park of Innovation and Technology of Ribeirão Preto, Gastroenterology Center of Connecticut, Clinics Hospital of Ribeirão Preto · ORCID：0000-0002-2208-3527

发表论文 112 篇 · 总被引 1451 次 · h-index 21

代表论文

• SGLT2 inhibition alters substrate utilization and mitochondrial redox in healthy and failing rat hearts (2024 · Journal of Clinical Investigation · 被引 47)
• Liver lipid droplet cholesterol content is a key determinant of metabolic dysfunction–associated steatohepatitis (2025 · Proceedings of the National Academy of Sciences · 被引 37)
• Ceramide synthesis inhibitors prevent lipid-induced insulin resistance through the DAG-PKCε-insulin receptorT1150 phosphorylation pathway (2024 · Cell Reports · 被引 28)
• Effect of Weight Loss on Skeletal Muscle Bioactive Lipids in People With Obesity and Type 2 Diabetes (2024 · Diabetes · 被引 16)
• Determinants of increased muscle insulin sensitivity of exercise-trained versus sedentary normal weight and overweight individuals (2025 · Science Advances · 被引 14)
• Cideb knockdown in mice increases mitochondrial fat oxidation and reverses hepatic steatosis and insulin resistance by the plasma membrane sn-1,2-DAGs–PKCε–insulin receptor kinaseT1150 pathway (2025 · Diabetologia · 被引 5)